Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medipharm Labs Corp MEDIF


Primary Symbol: T.LABS

Healthcare Cannabis
MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.


TSX:LABS - Post by User

Medipharm Labs Corp > CEO said, "we are undervalued". Okay, so how what is an
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(566)
•••
Comment by mdjbrownon Apr 20, 2024 10:30am
59 Views
Post# 35999471

RE:RE:RE:RE:RE:RE:RE:RE:RE:CEO said, "we are undervalued". Okay, so how what is an

RE:RE:RE:RE:RE:RE:RE:RE:RE:CEO said, "we are undervalued". Okay, so how what is an agree okgonow that they will need a lot of flower as international orders increase, but didnt they also pick up an additional growing facility with the Vivo takeover. If I am not mistaken they now have 3 large grow ops.

I dont know what the costs from flower to a finished Dronbinol product is, but Tilray also produces Dronbinol so it could have been a direct $ million dollar product swap to satisfy that portion of the settlement agreement. 

Still not certain if the other agreement committment includes a $500k per year over 4 years with Tilray, or a $125K per year supply agreement, but that settlement is coming to fruition.

Hoping Q1 clears a bit of that up, but it appears at least from the outside looking in that getting to profitability for Medipharm is closer with each quarter....... 


With it being 4/20 today, what other surprises are in store?
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities